
MiniMed Group, Inc. (MMED)
- Previous Close
20.10 - Open
19.97 - Bid 20.17 x 100
- Ask 25.49 x 200
- Day's Range
19.72 - 20.36 - 52 Week Range
10.65 - 20.88 - Volume
2,480,697 - Avg. Volume
1,197,142 - Market Cap (intraday)
5.7B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-1.30 - Earnings Date Sep 1, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
20.83
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.
www.minimed.com8,000
Full Time Employees
April 24
Fiscal Year Ends
Healthcare
Sector
Medical Instruments & Supplies
Industry
Recent News
View MorePerformance Overview
Trailing total returns as of 2026-08-31, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
Market Cap
5.49B
Enterprise Value
5.33B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.61
Price/Book (mrq)
1.52
Enterprise Value/Revenue
1.72
Enterprise Value/EBITDA
92.94
Financial Highlights
Profitability and Income Statement
Profit Margin
-10.73%
Return on Assets (ttm)
1.73%
Return on Equity (ttm)
-9.13%
Revenue (ttm)
3.1B
Net Income Avi to Common (ttm)
-333M
Diluted EPS (ttm)
-1.30
Balance Sheet and Cash Flow
Total Cash (mrq)
298M
Total Debt/Equity (mrq)
1.47%
Levered Free Cash Flow (ttm)
-71.75M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.









